We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

117 hedge funds and large institutions have $19.2M invested in Sanofi Contingent Value Rights in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

1% more funds holding

Funds holding: 116 → 117 (+1)

0% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 21

71% less capital invested

Capital invested by funds: $66.6M → $19.2M (-$47.4M)

Holders
117
Holders Change
+1
Holders Change %
+0.86%
% of All Funds
3.27%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
11
Increased
21
Reduced
21
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonehill Capital Management
New York
+$662K
2
GCM
Gruss Capital Management
New York
+$510K
3
PC
Pomelo Capital
New York
+$416K
4
WA
Whitebox Advisors
Minnesota
+$365K
5
DAM
Deltec Asset Management
New York
+$295K

Top Sellers

Rank Fund Capital Flow
1
PWAM
Park West Asset Management
California
-$428K
2
CPA
Columbia Pacific Advisors
Washington
-$166K
3
MCM
Moore Capital Management
New York
-$83.4K
4
IRF
IBM Retirement Fund
New York
-$49K
5
Millennium Management
Millennium Management
New York
-$41K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$59K +$3.68K +10,808 +4%
TL
27
TowerView LLC
New York
$57K -$28.9K -85,000 -22%
TI
28
Telemetry Investments
New York
$55K – – –
BCM
29
Basso Capital Management
Connecticut
$42K – – –
FRM
30
Fore Research & Management
New York
$36K – – –
Citadel Advisors
31
Citadel Advisors
Florida
$32K +$33.6K +98,879 +142%
YCM
32
Yakira Capital Management
Connecticut
$30K -$3.16K -9,300 -6%
First Eagle Investment Management
33
First Eagle Investment Management
New York
$28K – – –
UBS Group
34
UBS Group
Switzerland
$25K +$2.56K +7,518 +6%
EEG
35
E.E. Geduld
$24K -$8.5K -25,000 -17%
ZIG
36
Zuckerman Investment Group
Illinois
$19K -$272 -800 -0.8%
PP
37
Paloma Partners
Connecticut
$19K – – –
JP Morgan Chase
38
JP Morgan Chase
New York
$18K +$3.21K +9,439 +11%
CAS
39
CTC Alternative Strategies
Illinois
$14.4K – – –
Wells Fargo
40
Wells Fargo
California
$14K -$5.09K -14,975 -17%
GI
41
GAMCO Investors
Connecticut
$14K -$68 -200 -0.3%
ACA
42
Anchor Capital Advisors
Massachusetts
$11K -$663 -1,948 -3%
KAM
43
Kazazian Asset Management
Florida
$11K +$1.28K +3,778 +7%
OCM
44
Osterweis Capital Management
California
$10K – – –
Morgan Stanley
45
Morgan Stanley
New York
$9K -$91 -268 -0.6%
Korea Investment Corp
46
Korea Investment Corp
South Korea
$9K – – –
Commonwealth Equity Services
47
Commonwealth Equity Services
Massachusetts
$8K -$3.15K -9,253 -18%
CHAM
48
Clear Harbor Asset Management
Connecticut
$6K – – –
WC
49
Whitney & Co
New York
$6K – – –
WHI
50
William Harris Investors
Illinois
$6K – – –
1
2
3 4

GCVRZ Hedge Fund Activity: Q3 2015 in Review

117 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q3 2015, worth a combined $19.2M — down 71% from $66.6M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new GCVRZ positions and 10 closed out — a net gain of 1 holder — while 21 added to existing stakes and 21 trimmed.

The largest buyer was Stonehill Capital Management, opening a new position worth an estimated $662K. The largest seller was Park West Asset Management, exiting entirely with an estimated $428K sold.

  • 117 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q3 2015, up from 116 in Q2 2015.
  • Funds reported $19.2M of Sanofi Contingent Value Rights stock for Q3 2015, down 71% quarter-over-quarter.
  • 11 funds opened new Sanofi Contingent Value Rights positions in Q3 2015 and 10 closed out, a net change of +1 holder.
  • The largest Sanofi Contingent Value Rights buyer in Q3 2015 was Stonehill Capital Management, an estimated $662K added.
  • The largest Sanofi Contingent Value Rights seller in Q3 2015 was Park West Asset Management, an estimated $428K sold.

Based on aggregated 13F filings for Q3 2015.